Incyte to Report Fourth Quarter and Year-End 2024 Financial Results

Go back to Incyte to Report Fourth Quarter and Year-End 2024 Financial Results
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 128.83 +3.82 (3.06%)
Previous Close $125.01    52 Week High $118.49 
Open $126.43    52 Week Low $55.00 
Day High $129.56    P/E N/A 
Day Low $125.89    EPS $-0.56 
Volume 2,324,205